This blood test may predict kidney cancer risk 5 years in advance, says study

According to a study, a blood test could predict kidney cancer risk and survival, five years prior to its diagnosis.

By: ANI | | Published: August 11, 2018 7:32 pm

Kidney-injury-molecule-1 (KIM-1) can be detected in the urine and blood and is generally present at low levels in healthy individuals. In a new study, researchers at Brigham and Women’s Hospital explored whether a blood test can detect higher concentrations of KIM-1 in patients who will go on to develop kidney cancer up to five years later. Also Read - Is Sanjay Dutt suffering from lung cancer? Spot the early signs of this condition

Their results show that KIM-1 substantially helped distinguish between those who went on to develop kidney cancer from those who did not. Also Read - 5 anti-cancer foods that you must definitely add to your diet

“Early detection of kidney cancer can be lifesaving. We can cure kidney cancer when we detect it at an early stage, but patients with advanced kidney cancer have a very high death rate,” said Venkata Sabbisetti, adding, “However, kidney cancer is asymptomatic and many patients present with advanced kidney cancer at the time of diagnosis. Our results suggest that with further refinement, KIM-1 has the potential to identify patients with early, curable kidney cancer.” Also Read - Effective treatment for rare lymphoma may be here soon

The team reported that adding KIM-1 to a model for predicting kidney cancer risk approximately doubled the accuracy of that model. KIM-1 was substantially more sensitive for kidney cancer detection than prostate specific antigen is for prostate cancer. However, given how much rarer Renal cell carcinoma (RCC) is, the researchers noted that KIM-1 should be measured along with another kidney disease specific markers to be useful for early detection in the general population.

“We envision that KIM-1 will be useful in settings where the risk of kidney cancer is higher, such as patients undergoing abdominal CT scanning, where KIM-1 could be used to stratify risk of RCC,” the authors wrote. “This will be particularly important given the rise of routine CT scans and the strong association between number of CT scans and number of nephrectomies performed at the regional level in the U.S., indicating a substantial burden of overdiagnosis.”

The study appears in the journal Clinical Cancer Research.

Source: ANI
Image Source: Shutterstock

Published : August 11, 2018 7:32 pm

Read Disclaimer

Early onset of diabetes may cut girls' lifespan by 18 years, finds study

5 natural ways to get rid of bad breath

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Early onset of diabetes may cut girls' lifespan by 18 years, finds study

5 natural ways to get rid of bad breath

Is Sanjay Dutt suffering from lung cancer? Spot the early signs of this condition

5 anti-cancer foods that you must definitely add to your diet

Take care of your heart: Cardiovascular events increase breast cancer mortality

Cancer treatment breakthrough: DGLA fatty acid can kill malignant cells

Effective treatment for rare lymphoma may be here soon

About The health Site

Useful Links